Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARα

Molecular and Cellular Endocrinology

Volumn 220, Issue 1-2, 2004, Pages 51-58

  Kim, Sujong ^a   Shin, Hye Jin ^b   Kim, Sun Young ^c   Kim, Ji Hyun ^c   Lee, Yong Sung ^a   Kim, Duck Hee ^c   Lee, Mi Ock ^b  

^a Hanyang University   (South Korea)

^b Sejong University   (South Korea)

^c AmorePacific Corporation   (South Korea)

Author keywords

Carnitine palmitoyltransferase 1, liver form; Fatty acid oxidation; Genistein; Peroxisome proliferator activated receptor

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; ESTROGEN RECEPTOR; FATTY ACID; FULVESTRANT; GENISTEIN; ISOFLAVONE DERIVATIVE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL ASSAY; DOWNSTREAM PROCESSING; GENE EXPRESSION; GENE TARGETING; GENETIC ANALYSIS; HEPATOMA CELL; HUMAN; HUMAN CELL; LIPOLYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

CELL LINE, TUMOR; FATTY ACIDS; GENE EXPRESSION REGULATION; GENISTEIN; HUMANS; OXIDATION-REDUCTION; PPAR ALPHA; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS);

EID: 2942529395     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2004.03.011     Document Type: Article

References (41)

1. Adlercreutz H., Markkanen H., Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet. 342:1993;1209-1210
2. Assimacopoulos-Jeannet F., Thumelin S., Roche E., Esser V., McGarry J.D., Prentki M. Fatty acids rapidly induce the carnitine palmitoyltransferase-I gene in the pancreatic β-cell line INS-1. J. Biological. Chem. 272:1997;1659-1664
3. Bhathena S.J., Velasquez M.T. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am. J. Clin. Nutr. 76:2002;1191-1201
4. Borradaile N.M., Dreu L.E., Wilcox L.J., Edwards J.Y., Huff M.W. The soy phytoestrogens, genistein and daidzein, reduce apolipoprotein B secretion from HepG2 cells through multiple mechanisms. Biochem. J. 366:2002;531-539
5. Bremer J. The biochemistry of hypo and hyperlipidemic fatty acid derivatives: metabolism and metabolic effects. Prog. Lipid Res. 40:2001;231-268
6. Dang Z.C., Audinot V., Papapoulos S.E., Boutin J.A., Lowik C.W. Peroxisome proliferator-activated receptor γ (PPARγ) as a molecular target for the soy phytoestrogen genistein. J. Biol. Chem. 278:2003;962-967
7. Desvergne B., Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20:1999;649-688
8. Diel P., Smolnikar K., Schulz T., Laudenbach-Leschowski U., Michna H., Vollmer G. Phytoestrogens and carcinogenesis-differential effects of genistein in experimental models of normal and malignant rat endometrium. Hum. Reprod. 16:2001;997-1006
9. Dixon R.A., Ferreira D. Genistein. Phytochemistry. 60:2002;205-211
10. Djuric Z., Chen G., Doerge D.R., Heilbrun L.K., Kucuk O. Effect of soy isoflavone supplementation on markers of oxidative stress in men and women. Cancer Lett. 172:2001;1-6
11. Dubey R.K., Gillespie D.G., Zacharia L.C., Rosselli M., Korzekwa K.R., Fingerle J., Jackson E.K. Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms. Biochem. Biophys. Res. Commun. 278:2000;27-33
12. Gould Rothberg B.E., Sundseth S.S., DiPippo V.A., Brown P.J., Winegar D.A., Gottshalk W.K., Shenoy S.G., Rothberg J.M. The characterization of PPAR alpha ligand drug action in an in vivo model by comprehensive differential gene expression profiling. Funct. Integr. Genomics. 1:2001;294-304
13. Gower B.A., Nagy T.R., Blaylock M.L., Wang C., Nyman L. Estradiol may limit lipid oxidation via Cpt 1 expression and hormonal mechanisms. Obes. Res. 10:2002;167-172
14. Hsu M.-H., Savas Z., Griffin K.J., Johnson E.F. Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor a in HepG2 cells. J. Biol. Chem. 276:2001;27950-27958
15. Iqbal M.J., Yaegashi S., Ahsan R., Lightfoot D.A., Banz W.J. Differentially abundant mRNAs in rat liver in response to diets containing soy protein isolate. Physiol. Genomics. 11:2002;219-226
16. Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 103:1999;1489-1498
17. King R.A., Bursill D.B. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am. J. Clin. Nutr. 67:1998;867-872
18. Kliewer S.A., Forman B.M., Blumberg B., Ong E.S., Borgmeyer U., Mangelsdorf D.J., Umesono K., Evans R.M. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. U.S.A. 91:1994;7355-7359
19. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., Gustafsson J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors and β Endocrinology. 138:1997;863-870
20. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 139:1998;4252-4263
21. Lee M.-O., Kang H.J. Role of coactivators and corepressors in the induction of the RARbeta gene in human colon cancer cells. Biol. Pharm. Bull. 25:2002;1298-1302
22. Lee M.O., Kang H.J., Kim Y., Oum J.-H., Park J. Repression of FasL expression by retinoic acid involves a novel mechanism of inhibition of transactivation function of the nuclear factors of activated T-cells. Eur. J. Biochem. 269:2002;1162-1170
23. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method). Methods. 25:2001;402-408
24. Louet J.F., May C.L., Pégorier J.P., Decaux J.F., Girard J. Regulation of liver carnitine palmitoyltransferase-I gene expression by hormone and fatty acids. Biochem. Soc. Trans. 29:2001;310-316
25. Manning D.L., Nicholson R.I. Isolation of pMGT1: a gene that is repressed by oestrogen and increased by antioestrogens and antiprogestins. Eur. J. Cancer. 29A:1993;759-762
26. MerzDemlow B.E., Duncan A.M., Wangen K.E., Xu X., Carr T.P., Phipps W.R., Kurzer M.S. Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am. J. Clin. Nutr. 71:2000;1462-1469
27. Minnich A., Tian N., Byan L., Bilder G. A potent PPARalpha agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 280:2001;E270-279
28. Mogul, H.R., Wynn, P.S., Frey, M., 1998. Weight gain in menopause: the role of estrogen replacement and other factors. In: Proceedings of the Endocrine Society 80th Annual Meeting, p. 362.
29. Naaz A., Yellayi S., Zakroczymski M.A., Bunick D., Doerge D.R., Lubahn D.B., Helferich W.G., Cooke P.S. The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology. 144:2003;3315-3320
30. O'Sullivan A.J., Crampton L.J., Freund J., Ho K.K.Y. The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women. J. Clin. Invest. 102:1998;1035-1040
31. Peluso M.R., Winters T.A., Shanahan M.F., Banz W.J. A cooperative interaction between soy protein and its iso.avone-enriched fraction lowers hepatic lipids in male obese Zucker rats and reduces blood platelet sensitivity in male Sprague-Dawley rats. J. Nutr. 130:2000;2333-2342
32. Setchell K.D., Zimmer-Nechemias L., Cai J., Heubi J.E. Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet. 350:1997;23-27
33. Shao Z.M., Shen Z.Z., Fontana J.A., Barsky S.H. Genistein's ER-dependent and independent actions are mediated through ER pathways in ER-positive breast carcinoma cell lines. Anticancer Res. 20:2000;2409-2416
34. Staels B., Dallongeville J., Auwerx J., Schoonjans K., Leitersdorf E., Fruchart J.G. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation. 98:1998;2088-2093
35. Takahashi N., Kawada T., Goto T., Yamamoto T., Taimatsu A., Matsui N., Kimura K., Saito M., Hosokawa M., Miyashita K., Fushiki T. Dual action of isoprenols from herbal medicines on both PPARgamma and PPARalpha in 3T3-L1 adipocytes and HepG2 hepatocytes. FEBS Lett. 514:2002;315-322
36. Tham D.M., Gardner C.D., Haskell W.L. Potential health benefits of dietary phytoestrogens: a review of the clinical, epidermiological, and mechanistic evidence. J. Clin. Endocrinol. Metab. 83:1998;2223-2235
37. Watanabe S., Yamaguchi M., Sobue T., Takahashi T., Miura T., Arai Y., Mazur W., Wahala K., Adlercreutz H. Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J. Nutr. 128:1998;1710-1715
38. Weinstein I., Cook G.A., Heimberg M. Regulation by oestrogen of carnitine palmitoyltransferase in hepatic mitochondria. Biochem. J. 237:1986;593-596
39. Willson T.M., Wahli W. Peroxisome proliferator-activated receptor (PPAR) agonists. Curr. Opin. Chem. Biol. 1:1997;235-241
40. Wiseman H. The bioavailability of non-nutrient plant factors: dietary flavonoids and phyto-oestrogens. Proc. Nutr. Soc. 58:1999;139-146
41. Xu X., Harris K.S., Wang H.J., Murphy P.A., Hendrich S. Bioavailability of soybean isoflavones depends upon gut microflora in women. J. Nutr. 125:1995;2307-2315